Associated tags: Patient, DSM-IV codes, Parkinson's disease, Central nervous system disease, Mouse, Parkinson's disease dementia, Cancer, Research, Epilepsy, Rett syndrome, CNS, Deficit spending, Therapy, Pain, Amyloid, Central nervous system, News, Excellence, Pharmaceutical industry, Complaint
Locations: SAN FRANCISCO, AUSTRALIA, CANADA, ŌTSUKA, UK, ATLANTA, GA, TD, NEW YORK, NY, US, BS, EUROPE, ASIA, USA, AD, LOS ANGELES, TEL AVIV, CHICAGO, PARIS, LONDON, LEVI, UNITED STATES, CA, CALIFORNIA, GEORGIA, PENNSYLVANIA, EUROPEAN UNION, PK, BENSALEM, PA, III, SAN DIEGO, NORTH AMERICA
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
Key Points:
- Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
- The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
- Faruqi & Faruqi, LLP also encourages anyone with information regarding Anavex’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
- The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Investors who purchased the Company’s securities between February 1, 2022 and January 1, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before May 13, 2024.
Key Points:
- Investors who purchased the Company’s securities between February 1, 2022 and January 1, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before May 13, 2024.
- We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
- The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
- This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
MCI,
LLP,
News,
CLASS,
Radar,
NEXT,
Rett syndrome,
Patient,
Court,
Clinical trial,
Telephone,
COST NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
Key Points:
- NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
- CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Anavex Life Sciences investors who were adversely affected by alleged securities fraud between February 1, 2022 and January 1, 2024.
- Follow the link below to get more information and be contacted by a member of our team:
AVXL investors may also contact Joseph E. Levi, Esq.
- For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
LOS ANGELES, May 06, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
Key Points:
- LOS ANGELES, May 06, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
- Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
- This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
- The Law Offices of Frank R. Cruz, Los Angeles
MCI,
LLP,
News,
CLASS,
Radar,
NEXT,
Rett syndrome,
Patient,
Court,
Clinical trial,
Telephone,
COST NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
Key Points:
- NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
- CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Anavex Life Sciences investors who were adversely affected by alleged securities fraud between February 1, 2022 and January 1, 2024.
- Follow the link below to get more information and be contacted by a member of our team:
AVXL investors may also contact Joseph E. Levi, Esq.
- For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL).
Key Points:
- NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL).
- Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- The class action concerns whether Anavex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Anavex Life Sciences Corporation (NASDAQ: AVXL).
Key Points:
- NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Anavex Life Sciences Corporation (NASDAQ: AVXL).
- Shareholders who purchased shares of AVXL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
- The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
Key Points:
- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
- Investors have until the deadlines listed below to file a lead plaintiff motion.
- Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to [email protected] .
- Law Offices of Howard G. Smith
FDA,
News,
Central nervous system disease,
Complaint,
Rett syndrome,
Neurodevelopmental disorder,
Research,
CNS,
Avatar,
Patient,
Court,
Central nervous system,
Excellence,
Person,
Fraud,
Pharmaceutical industry Anavex has sponsored several research studies concerning blarcamesine’s suitability to treat various CNS disorders.
Key Points:
- Anavex has sponsored several research studies concerning blarcamesine’s suitability to treat various CNS disorders.
- or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
- If you suffered a loss in Anavex you have until May 13, 2024, to request that the Court appoint you as lead plaintiff.
- Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.
Retrieved on:
Wednesday, April 24, 2024
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) for securities law violations.
Key Points:
- BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) for securities law violations.
- Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those losses.
- The study failed to show statistical significance towards its primary endpoints, causing shares of Anavex Life Sciences Corp. stock to drop approximately 35%.
- Block & Leviton is widely regarded as one of the leading securities class action firms in the country.
